Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Reavis

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Cell Reports|March 3, 2021
MMB-FOXM1-driven premature mitosis is required for CHK1 inhibitor sensitivityTimothy B Branigan, David Kozono, Amy E Schade, et al.
Communications Biology|December 12, 2022
L1CAM is required for early dissemination of fallopian tube carcinoma precursors to the ovaryKai Doberstein, Rebecca Spivak, Hunter D Reavis, et al.
Cancer Research Communications|April 17, 2026
Alprazolam reduces inflammatory cytokine production in pancreatic cancer-associated fibroblastsHunter D Reavis, Aditi H Chaubey, Amanda L Smythers, et al.
JCI Insight|January 25, 2024
Norepinephrine induces anoikis resistance in high-grade serous ovarian cancer precursor cellsHunter D Reavis, Stefan M Gysler, Grace B McKenney, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
A targetable opioid/cancer associated fibroblast axis drives extracellular matrix remodeling and tumor aggressiveness in pancreatic cancerKathryn E Maraszek, Arwen A Tisdale, Hunter D Reavis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2019
The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP InhibitionKalindi Parmar, Bose S Kochupurakkal, Jean-Bernard Lazaro, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cell Reports|March 3, 2021
MMB-FOXM1-driven premature mitosis is required for CHK1 inhibitor sensitivityTimothy B Branigan, David Kozono, Amy E Schade, et al.
Communications Biology|December 12, 2022
L1CAM is required for early dissemination of fallopian tube carcinoma precursors to the ovaryKai Doberstein, Rebecca Spivak, Hunter D Reavis, et al.
Cancer Research Communications|April 17, 2026
Alprazolam reduces inflammatory cytokine production in pancreatic cancer-associated fibroblastsHunter D Reavis, Aditi H Chaubey, Amanda L Smythers, et al.
JCI Insight|January 25, 2024
Norepinephrine induces anoikis resistance in high-grade serous ovarian cancer precursor cellsHunter D Reavis, Stefan M Gysler, Grace B McKenney, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
A targetable opioid/cancer associated fibroblast axis drives extracellular matrix remodeling and tumor aggressiveness in pancreatic cancerKathryn E Maraszek, Arwen A Tisdale, Hunter D Reavis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2019
The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP InhibitionKalindi Parmar, Bose S Kochupurakkal, Jean-Bernard Lazaro, et al.
Pageof 2